Drawing for ELEVATEBIO

USPTO serial 88157955

ELEVATEBIO

Reviewed by CopyMark Law Group

Reg. 6511815Status 700Renewal
Filing date
Status date
Registration date
Oct 5, 2021
Examiner
MUNN LEWIS, LAKEISHA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELEVATEBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Research and development of medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapyACTIVEJul 25, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 31, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 30, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 22, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 15, 2021IUAFUSE AMENDMENT FILED—
Jul 15, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 15, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Jun 15, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jun 15, 2021PETGPETITION TO REVIVE-GRANTED—
Jun 15, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Jun 14, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 14, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 12, 2021EXT2SOU EXTENSION 2 FILED—
Mar 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2021EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 14, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Dec 14, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 14, 2020PETGPETITION TO REVIVE-GRANTED—
Dec 14, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Dec 14, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 14, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 12, 2020EXT1SOU EXTENSION 1 FILED—
May 12, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 12, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 12, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 12, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 12, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 2, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Apr 2, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Sep 16, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 22, 2019DOCKASSIGNED TO EXAMINER—
Apr 16, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2019DOCKASSIGNED TO EXAMINER—
Oct 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance